Pulmatrix (PULM) FCF Margin (2014 - 2025)
Pulmatrix (PULM) reported FCF Margin of -42033.33% for Q4 2024, down 41928.16 percentage points from -105.18% a year earlier and down 41197.54 percentage points from the prior quarter.
Powered by 
Analysis
Pulmatrix (PULM) FCF Margin (2014 - 2025) Analysis & Trends
For FY2024, Pulmatrix posted FCF Margin of -142.38%, up 85.92 percentage points from FY2023.
- FCF Margin has increased for three consecutive years, though with a five-year change of -182.48 percentage points (FY2019 to FY2024).
- By year, FCF Margin came in at -228.30% in FY2023 (+91.95 pp), -320.24% in FY2022 (+64.18 pp), -384.43% in FY2021 (-283.40 pp) and -101.03% in FY2020 (-141.13 pp).
- The Q4 2024 figure ranks as the lowest quarterly FCF Margin since Q1 2014.
- Year over year, FCF Margin gained in five of the last eight quarters, with an average year-over-year change of -5225.48 percentage points.
- The high point for year-over-year FCF Margin in five years was Q4 2022 (a gain of 673.78 percentage points); the low point was Q4 2024 (a drop of 41928.16 percentage points).
- Per Business Quant data, the three quarters before Q4 2024 came in at -835.79% (Q3 2024), -252.64% (Q2 2024) and -48.82% (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.91 Bn | 1,101.50 Bn | 19.71 Bn | 33.76% |
| 2 | Johnson & Johnson | 615.07 Bn | 533.59 Bn | 17.26 Bn | 28.82% |
| 3 | AbbVie | 505.92 Bn | 479.03 Bn | 12.70 Bn | 18.33% |
| 4 | Merck | 368.10 Bn | 322.48 Bn | 12.21 Bn | 26.96% |
| 5 | Novartis Ag | 298.25 Bn | 262.24 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 261.76 Bn | 235.45 Bn | 12.86 Bn | 6.55% |
| 7 | Amgen | 236.19 Bn | 191.59 Bn | 7.24 Bn | 34.70% |
| 8 | Gilead Sciences | 190.38 Bn | 164.57 Bn | 6.22 Bn | 44.00% |
| 9 | Pfizer | 170.37 Bn | 117.02 Bn | 10.94 Bn | 2.01% |
| 10 | Pulmatrix | 5.15 Mn | -9.26 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -3,420.75% |
| Dec 31, 2024 | -42,033.33% |
| Sep 30, 2024 | -835.79% |
| Jun 30, 2024 | -252.64% |
| Mar 31, 2024 | -48.82% |
| Dec 31, 2023 | -105.18% |
| Sep 30, 2023 | -254.14% |
| Jun 30, 2023 | -265.94% |
| Mar 31, 2023 | -328.75% |
| Dec 31, 2022 | -295.96% |
| Sep 30, 2022 | -192.52% |
| Jun 30, 2022 | -347.78% |
| Mar 31, 2022 | -530.52% |
| Dec 31, 2021 | -969.74% |
| Sep 30, 2021 | -319.18% |
| Jun 30, 2021 | -289.44% |
| Mar 31, 2021 | -395.32% |
| Dec 31, 2020 | -142.55% |
| Sep 30, 2020 | -128.43% |
| Jun 30, 2020 | -142.86% |
API Access
Pulmatrix FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=PULM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "PULM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=PULM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();